Effect of thyroxine on plasminogen activator and inhibitor activity in rat

Indian Journal of Experimental Biology

Volumn 47, Issue 2, 2009, Pages 147-150

  Bubber, P ^a,b   Bubber, N ^a   Bansal, D D ^a  

^a PANJAB UNIVERSITY   (India)

^b BANASTHALI UNIVERSITY   (India)

Author keywords

Fibrinolytic parameters; Homeostatic balance; Renal function; Thyroxine

Indexed keywords

RATTUS;

LIPID; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; THYROXINE;

ANIMAL; ARTICLE; BLOOD; DRUG EFFECT; GLUCOSE BLOOD LEVEL; MALE; RAT; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; LIPIDS; MALE; PLASMINOGEN ACTIVATORS; PLASMINOGEN INACTIVATORS; RATS; RATS, WISTAR; THYROXINE;

EID: 69249216713     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Squizzato A, Gerdes V E, Ageno W & Büller H R, The coagulation system in endocrine disorders: a narrative review, Intern Emerg Med, 2 (2007) 76.
2. Hofbauer L C & Heufelder A E, Coagulation disorders in thyroid diseases, Eur J Endocrinol, 136 (1997) 1.
3. Molitoris B A & Sutton T A, Endothelial injury and dysfunction: role in the extension phase of acute renal failure, Kidney Int, 66 (2004) 496.
4. Capasso G, De Santo N G & Kinne R, Thyroid hormones and renal transport: cellular and biochemical aspects, Kidney Int, 32 (1987) 443.
5. Djurica S, Radlovic O & Stanojcic A. Fast, Short-term thyroid gland reserve in patients on hemodialysis and its clinical importance, Nephrology Dialysis Transplantation, 15 (2000) A181.
6. Angles-Cano E, Rondeau E & Delarue, Identification and cellular localization of PA from human glomeruli, Thromb Haemost, 54 (1985) 688.
7. Dong BJ. Thyroid disorders in Applied therapeutics: The clinical use of drugs edited by M Koda-Kimble, L Young, A Wayne and B Guglielmo (Lippincott Williams & Wilkins, Baltimore, MD) 2001, 47.
8. Verheijen J H, Chang G T G & Kluft C, Evidence for the occurrence of a fast acting inhibitor of PA in human plasma, Thromb Haemostas, 51 (1984) 392.
9. Middleton J E & Griffiths W J, Rapid colorimetric micromethod for estimating glucose in blood and CSF using glucose oxidase, Brit Med J, 2 (1957) 1525.
10. Zlatkis A, Zak B & Boyle A J, A new method for the direct determination of serum cholesterol, J Lab Clin Med, 41 (1953).
11. Bucolo G & David H, Quantitative determination of serum triglycerides by the use of enzymes, Clin Chem, 19 (1973) 476.
12. Lopex-Vireflla M F L, Stone P G & Coldwell J A, Serum HDL in diabetic patients, Diabetologia, 13 (1977) 285.
13. Friedewald W T, Levy R I & Fredrickson, D S, Estimation of the concentration of LDL in cholesterol without use of ultracentrifuge, Clin Chem, 18 (1972) 499.
14. Brakman P, Albrechtsen O K & Astrup T, A comparative study of coagulation and fibrinolysis in blood from normal men and women, Br J Haematol, 12 (1966) 74.
15. Bansal D D & MacGregor R R, Calcium regulated secretion of tPA and PTH from human parathyroid, J Clin Endocrinol Metab, 74 (1992) 266.
16. Lowry O H, Rosebrough N J, Farr A L & Randall R J, Protein measurement with folin-phenol reagent, J Biol Chem, 193 (1951) 265.
17. Devarajan P, Update on Mechanisms of Ischemic Acute Kidney Injury, J Am Soc Nephrol, 17 (2006) 1503.
18. Adamson LF & Ingbar SH, Some properties of the stimulatory effect of thyroid hormones on amino acid transport by embryonic chick bone, Endocrinology, 81 (1967)1372.
19. Barouski-Miller PA & Gelehrter TD, Paradoxical effects of glucocorticoids on regulation of plasminogen activator activity of rat hepatoma cells, Proc Natl Acad Sci USA, 79 (1982) 2319.
20. Kluft C, Jie AF, Rijken DC & Verheijen JH, Daytime fluctuations in blood of tissue-type plasminogen activator (t- PA) and its fast-acting inhibitor (PAI-1), Thromb Haemost, 59 (1988) 329.
21. Huber K, Rosc D, Resch I, Schuster E, Glogar DH, Kaindl F & Binder BR, Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction, Thromb Haemost, 60 (1988) 372.
22. Rennie JA, Bewsher PD, Murchison LE & Ogston D. Coagulation and fibrinolysis in thyroid disease, Acta Haematol. 59 (1978)171.
23. Padró T, van den Hoogen CM & Emeis JJ, Experimental hypothyroidism increases plasminogen activator inhibitor activity in rat plasma, Blood Coagul Fibrinolysis, 5 (1993) 797.
24. Müller MJ, Acheson KJ, Jequier E & Burger AG. Effect of thyroid hormones on oxidative and nonoxidative glucose metabolism in humans, Am J Physiol, 2 Pt 1 (1988) E146.
25. Valdemarsson S. Plasma lipoprotein alterations in thyroid dysfunction. Roles of lipoprotein lipase, hepatic lipase and LCAT, Acta Endocrinol Suppl (Copenh), 255 (1983) 1.
26. Abrams JJ & Grundy SM, Cholesterol metabolism in hypothyroidism and hyperthyroidism in man, J Lipid Res, 2 (1981) 323.
27. Miller JL, Clinical investigation of thyroid disorders, S Afr Med J, 59 (1981) 593.
28. Rao SN, Cortese C, Miller NE, Levy Y & Lewis B, Effects of heparin infusion on plasma lipoproteins in subjects with lipoprotein lipase deficiency. Evidence for a role of hepatic endothelial lipase in the metabolism of high-density lipoprotein subfractions in man, FEBS Lett, 150 (1982) 255.